GlaxoSmithKline logo

Nominations Committee

Membership:

Chairman: Sir Christopher Gent
Members:

Mr L Culp
Sir Crispin Davis
Sir Deryck Maughan
Sir Robert Wilson

Secretary: Simon Bicknell
In attendance: Chief Executive Officer
Frequency of meetings: The committee meets at least once a year to consider succession planning, with other meetings held as required.


The Nominations Committee reviews the structure, size and composition of the board and its committees and the appointment of members of the Board and the CET, and makes recommendations to the Board as appropriate. The committee also monitors the planning of succession to the Board and senior management. The committee consists entirely of Non-Executive Directors of whom a majority are independent.

The Nominations Committee's report for 2008 is included in the company's 2008 Annual Report.



Back to top